Panitumumab User Reviews & Ratings
Brand names: Vectibix
Panitumumab has an average rating of 5.2 out of 10 from a total of 7 reviews on drugclasses.com. 50% of reviewers reported a positive experience, while 50% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Colorectal Cancer | 7 reviews for Colorectal Cancer | 28 medications | |
Add your review |
- Glenn...
- March 29, 2016
Vectibix (panitumumab) for Colorectal Cancer "Its bad enough to have cancer, but this drug doesn't work and turns patients into lepers"
- Alaska...
- Taken for 1 to 6 months
- July 24, 2023
For Colorectal Cancer "All tumors gone - way better results than expected. Rash / skin conditions small price to pay. Who doesn't want a second chance at puberty?"
- Anonymous
- Taken for 1 to 6 months
- November 8, 2017
Vectibix (panitumumab) for Colorectal Cancer "This medication has my carcinoembryonic antigen (CEA) test numbers way down . I hate the rash but at least I'm alive."
- Anonymous
- Taken for 1 to 6 months
- December 27, 2017
Vectibix (panitumumab) for Colorectal Cancer "Have been on this 8-2017 and my CEA marker is down from 16.1 to 3.6. Side effect of dry skin is tolerable."
Are you taking this medicine?
- worst...
- August 30, 2016
For Colorectal Cancer "would not recommend this drug to anyone, terrible experience, ended up having a heart attack besides, never had heart problems until taking this drug!!!!"
- Anonymous
- Taken for 6 months to 1 year
- November 29, 2022
For Colorectal Cancer "I have horrible skin rashes over my entire body. Also cause infections on my toes that nothing seemed to be able to get rid of. I asked my doctor to discontinue use because my skin rashes were so bad."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about panitumumab
- Check interactions
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Vectibix (panitumumab) for Colorectal Cancer "Vectibix reduced my CEA (cancer marker) from 25.2 all the way down to 2.5 within the matter of a few months. The skin reaction SUCKS. Thankfully Ia able to undergo a revolutionary surgery to remove the portion of my liver with the metastatic cancer so I have just recently been able to stop the Vectibix. I am hoping I will get my beautiful skin back."